Theorem Clinical Research

Parexel

Parexel to acquire Quantum Solutions India

Thursday, March 26, 2015 02:56 PM

Parexel International, a Boston-based global CRO, has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (QSI), a provider of specialized pharmacovigilance services.

More... »

Quest Diagnostics

Biosimilars Provide New Business Opportunities for Sites

Monday, March 9, 2015 08:00 AM

Significant factors involved in the growth and potential impact of biosimilars include budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for low-cost alternatives, an increasingly aging population, government initiatives and rising incidences of various diseases.

More... »


Parexel continues to expand Site Alliance Network

Wednesday, February 18, 2015 11:51 AM

Parexel International, a global biopharmaceutical services provider, has announced the continued expansion of its clinical trial Site Alliance Network, an extensive network of investigator sites and site management organizations (SMOs) that enables Parexel to quickly access and enroll patient populations for clients' clinical trials worldwide.

More... »

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »

Parexel recognized as a 2015 Training Top 125 by Training Magazine

Wednesday, February 11, 2015 02:41 PM

Parexel International, a global biopharmaceutical services provider, has been recognized among top U.S. businesses in Training magazine's annual "Training Top 125." Parexel earned a place in the ranking this year for developing creative and effective employee learning and development initiatives for their global workforce.

More... »

Parexel ClinPhone RTSM named interactive response technology leader

Monday, December 15, 2014 12:48 PM

Parexel International, a global biopharmaceutical services provider, has announced that its randomization and trial supply management (RTSM) services, ClinPhone RTSM, ranked as the leader of Interactive Response Technology (IRT), according to a new global survey of pharmaceutical and biotechnology companies by Industry Standard Research (ISR). ClinPhone RTSM also was cited as the most preferred and widely used IRT solution.

More... »

As GSK restructuring cuts 900 jobs in RTP, Parexel absorbs 450 of them in new business unit

Monday, December 8, 2014 01:30 PM

GlaxoSmithKline’s global restructuring was felt sharply in North Carolina this week as it announced plans to cut 900 jobs in Research Triangle Park (RTP), where it has 2,500 employees and contractors working in research and development.

More... »

BioClinica names John Hubbard CEO

Wednesday, December 3, 2014 01:05 PM

BioClinica, a Pennsylvania-based CRO, has appointed John Hubbard, Ph.D., FCP, as CEO and to its board of directors. Hubbard will assume the CEO position on Jan. 5, 2015 from Mark Weinstein.

More... »

NextDocs joins the Parexel Perceptive Partner Program

Monday, November 24, 2014 02:41 PM

NextDocs, a Conshohocken, Pa.-based provider of regulated content management and compliance solutions for the life sciences industry, has joined the Parexel Perceptive Partner Program. NextDocs will enhance and broaden its services to biopharmaceutical customers by leveraging the Perceptive MyTrials eClinical platform, a suite of applications for managing clinical trials. 

More... »

Parexel opens new European coordination hub and distribution center

Friday, November 14, 2014 10:50 AM

Global CRO Parexel International has opened its new European Coordination Hub and Distribution Center in Berlin-Schönefeld, Germany.  

More... »


CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs